iVisit vs DocAlert
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
iVisit
Connect with your healthcare provider through secure text messaging, video calls, and asynchronous question-based visits. This telemedicine solution facilitates efficient communication between patients and providers from your mobile device.
- Secure text messaging
- Video visits
- Asynchronous question-based visits
- HIPAA compliant
- Provider-patient communication
Read full descriptionHide full description
GenieMD iVisit makes connecting with your Provider quicker and easier from the convenience of your mobile device. iVisit offers a telemedicine solution that allows Providers and Patients to communicate more efficiently by using secure, HIPAA compliant text messaging, video visits and question-based asynchronous visits.
DocAlert
This medical app connects patients experiencing herpes outbreaks with physicians for remote diagnosis and prescription services. It prioritizes user privacy through an encrypted platform, ensuring sensitive information is only accessible to assigned doctors. The service aims to provide timely treatment and reduce the stigma associated with the Herpes Simplex Virus.
- Remote physician consultation
- Herpes outbreak diagnosis
- Prescription services
- Secure encrypted platform
- Patient privacy protection
- Photo submission for diagnosis
Read full descriptionHide full description
HA Telehealth is a telehealth application that provides a private liaison between a physician and a patient who is suffering from a Herpes outbreak. Through our platform, the physician will have access to a patient’s basic information, photos of the herpes outbreak, and an answered questionnaire that the patient previously filled out. The physician will use the application to diagnose a patient who is experiencing herpes symptoms and whether the patient would need a prescription. HerpAlert ensures protection through our encrypted and secure algorithm. Patient privacy and security is our utmost concern. The patient's information is only seen by their assigned physician. Furthermore, after receiving a diagnosis and prescription, the patient's personal information is completely deleted and destroyed from our database. The Herpes Simplex Virus is one of the most prevalent STDs and unlike its counterparts, HSV can’t be cured. Research shows that 2 in 3 people are infected with HSV1 while 1 in 5 people are infected with HSV2. An estimated 776,000 new cases of HSV2 occur each year in the U.S. HerpAlert will help millions of people receive a prescription before and during an outbreak. HerpAlert has teamed up with physicians who share the same passion in relieving the Herpes Simplex Virus stigma by helping our patients receive a prescription before a nasty outbreak.
Screenshots
Verdict
The clearest difference is review sentiment: iVisit at 85% against DocAlert's 0%. iVisit also leads on rating (4.5 vs 3.3) and update cadence (every 2 weeks vs every 5 weeks). DocAlert's advantage is ads (none vs shown) and monetization model (free vs ad-supported). On price, in-app purchases, device support and iOS requirement there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
iVisit holds the better App Store score, 4.5 against 3.3. That said, the two scores are not equally well evidenced: iVisit has 65 ratings behind it against 7, so its average is the more settled of the two. Written reviews point the same way: 85% of iVisit's written reviews are positive against 0% of DocAlert's.
iVisit ships an update every 2 weeks, DocAlert every 5 weeks. The most recent releases landed on October 8, 2026 and October 14, 2026 respectively.
| Parameter | iVisit | DocAlert |
|---|---|---|
| Price | Free | Free |
| Rating | 4.5 (65 ratings) — better | 3.3 (7 ratings) |
| Positive reviews | 85.2% of reviews — better | 0.0% of reviews |
| Number of ratings | 65 — better | 7 |
| Update frequency | Every 2 weeks — better | Every 5 weeks |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Ad-supported | Free — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 12.0 — better | 13.2 |
| Further details — not scored | ||
| Size | 151 MB | 2 MB |
| Age rating | 17+ | 17+ |
| Developer | GenieMD, Inc. | Derma Corporation |
Customer experience
iVisit
DocAlert
In-app purchases
iVisit
No in-app purchases
DocAlert
No in-app purchases






